USPTO serial 79307287
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
GB
GB
GB
GB
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Rebecca Liebowitz
Rebecca Liebowitz Venable LLPP.O. Box 34385Washington, DC 20043-9998UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 001 | chemical preparations for scientific purposes, other than for medical or veterinary use; chemicals for research use, namely, nucleic acid sequences for laboratory or research use; enzymes for research use; DNA and RNA for research use, namely, nucleic acid sequences for laboratory use, nucleic acid sequences for other than medical and veterinary purposes; chemicals for use in the preparation and creation of DNA and RNA, reagents for scientific purposes, other than for medical or veterinary use; enzymes for use in the preparation and creation of DNA and RNA, namely, enzymes for scientific and research purposes; molecular biology research tools in the nature of biological, chemical and biochemical reagents for research use | ACTIVE | — |
| 005 | Pharmaceutical preparations for the treatment and prevention of ophthalmological conditions, hearing loss, hematologic diseases, immune response disorders, neurological disorders, respiratory diseases, fibrosis, hepatic diseases, renal diseases, diseases of the pancreas, metabolic diseases, genetic conditions, cancer, infectious diseases and cardiovascular diseases; medical and veterinary preparations for therapeutic purposes for the treatment and prevention of ophthalmological conditions, hearing loss, hematologic diseases, immune response disorders, neurological disorders, respiratory diseases, fibrosis, hepatic diseases, renal diseases, diseases of the pancreas, metabolic diseases, genetic conditions, cancer, infectious diseases and cardiovascular diseases; biological, chemical and biochemical reagents, namely, DNA and RNA sequences and gene editing enzymes, all for medical use; DNA and RNA products for medical use, namely, nucleic acid sequences for medical purposes; therapeutic DNA and RNA, namely, nucleic acid sequences for medical purposes | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 21, 2025 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Mar 2, 2024 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| May 30, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 4, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 4, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 30, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 31, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jan 31, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Nov 15, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 15, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 14, 2022 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Oct 26, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 26, 2022 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Oct 26, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 13, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 20, 2022 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Sep 7, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 31, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 31, 2022 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Aug 22, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 20, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 20, 2022 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jul 15, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 14, 2022 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Apr 14, 2022 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 14, 2022 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 14, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 25, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 25, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 25, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 11, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 25, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 25, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 12, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 11, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 9, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 2, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 29, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 25, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |